In Medicare, a $170m savings for Raytheon
Drug benefits shift for retirees
Raytheon Co. will save $170 million by using a new Medicare plan to shift some expenses for retirees' prescriptions to taxpayers. (Full article: 758 words)
This article is available in our archives:
Globe Subscribers
FREE for subscribers
Subscribers to the Boston Globe get unlimited access to our archives.
Not a subscriber?
Non-Subscribers
Purchase an electronic copy of the full article. Learn More
- $4.95 1 article
- $9.95 4 articles
- $25.95 Monthly
